Titan Biotech

{
  "main_header": {
    "sid": 779371,
    "name": "Titan Biotech",
    "stock_name": "Titan Biotech",
    "full_name": "Titan Biotech Ltd",
    "name_url": "stocks-analysis/titan-biotech",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "454.95",
    "chg": 10.2,
    "chgp": "2.29%",
    "dir": 1,
    "prev_price": "444.75",
    "mcapval": "1,879.79 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524717,
    "symbol": "",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "sector_id": 74,
    "indexname": "India SENSEX",
    "isin": "INE150C01029",
    "curr_date": "Jun 15, 01:58 PM",
    "curr_time": "13:59 PM",
    "last_traded_at": "Jun 15, 01:58 PM IST",
    "bse_nse_vol": "27.66 k",
    "exc_status": "Active",
    "traded_date": "Jun 15, 2026",
    "traded_date_str": "2026 06 15",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/titan-biotech-779371-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MN",
      "url": "https://www.marketsmojo.com/mojopro/strategy/2",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/titan-biotech-779371-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Titan Biotech Gains 0.24%: 4 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/titan-biotech-gains-024-4-key-factors-driving-the-weeks-momentum-4052233",
        "imagepath": "",
        "date": "2026-06-13 17:09:58",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> Stock opens strong at Rs.456.60, up 3.48%</p>\n                    <p><strong>2 June:</strong> Titan Biotech upgraded to Buy by MarketsMOJO</p>\n                    <p><strong>4 June:</strong> Technical momentum shifts to mildly bullish amid mixed signals</p>\n                    <p><strong>5 June:</strong> Week closes steady at Rs.442.30, outperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.441.25</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.442.30..."
      },
      {
        "title": "Titan Biotech Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/titan-biotech-ltd-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-4040420",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/TitanBiotechLtd_mojoScore_4040420.png",
        "date": "2026-06-09 08:24:00",
        "description": "Titan Biotech Ltd, a micro-cap player in the Specialty Chemicals sector, has seen its investment rating downgraded from Buy to Hold as of 8 June 2026. This revision reflects a nuanced assessment across four key parameters: quality, valuation, financial trend, and technical indicators. Despite robust recent financial performance and impressive long-term returns, evolving technical signals and valuation concerns have tempered the overall outlook."
      },
      {
        "title": "Titan Biotech Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/titan-biotech-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4035253",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/TitanBiotechLtd_technicaldot_4035253.png",
        "date": "2026-06-04 08:03:40",
        "description": "Titan Biotech Ltd, a micro-cap player in the specialty chemicals sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a recent downgrade in daily price performance, the company’s long-term returns remain robust, prompting a reassessment of its technical outlook and investment potential."
      },
      {
        "title": "Are Titan Biotech Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-titan-biotech-ltd-latest-results-good-or-bad-4032355",
        "imagepath": "",
        "date": "2026-06-02 19:26:39",
        "description": "Titan Biotech Ltd's latest financial results for Q4 FY26 reveal a mixed operational performance characterized by significant year-on-year growth alongside sequential declines. The consolidated net profit reached ₹6.73 crores, reflecting a notable year-on-year increase of 66.17%. However, this figure represents a decline of 21.10% compared to the previous quarter. Similarly, net sales for the quarter amounted to ₹48.83 crores, which is a substantial year-on-year growth of 38.84%, yet it shows a sequential decrease of 13.59% from Q3 FY26.\n\nThe operating margin for the quarter stood at 19.89%, marking a significant improvement of 690 basis points from the same quarter last year, indicating effective cost management and operational leverage despite inflationary pressures. The average return on equity (ROE) of 21.23% demonstrates strong capital efficiency, positioning the company favorably within its industry.\n\n..."
      },
      {
        "title": "Titan Biotech Ltd Upgraded to Buy on Strong Financials and Technical Momentum",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/titan-biotech-ltd-upgraded-to-buy-on-strong-financials-and-technical-momentum-4030075",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/TitanBiotechLtd_mojoScore_4030075.png",
        "date": "2026-06-02 08:28:21",
        "description": "Titan Biotech Ltd, a micro-cap player in the specialty chemicals sector, has seen its investment rating upgraded from Hold to Buy as of 1 June 2026. This upgrade reflects a comprehensive improvement across key parameters including quality, valuation, financial trends, and technical indicators, signalling renewed investor confidence in the company’s prospects."
      },
      {
        "title": "Titan Biotech Ltd Sees Bullish Momentum Shift Amid Technical Upgrades",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/titan-biotech-ltd-sees-bullish-momentum-shift-amid-technical-upgrades-4029614",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/TitanBiotechLtd_technicaldot_4029614.png",
        "date": "2026-06-02 08:06:37",
        "description": "Titan Biotech Ltd, a micro-cap player in the Specialty Chemicals sector, has exhibited a notable shift in its technical momentum, signalling a bullish outlook after a period of mild bullishness. The stock’s recent price action, combined with evolving technical indicators such as MACD, RSI, and moving averages, suggests an improving trend that investors should closely monitor amid its strong long-term returns."
      },
      {
        "title": "Titan Biotech Q4 FY26: Strong Growth Momentum Marred by Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/titan-biotech-q4-fy26-strong-growth-momentum-marred-by-valuation-concerns-4030855",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/TitanBiotech_quaterlyResult_4030855.png",
        "date": "2026-06-01 23:47:58",
        "description": "Titan Biotech Ltd., the New Delhi-based speciality chemicals manufacturer, reported robust financial performance for Q4 FY26, with consolidated net profit surging 66.17% year-on-year to ₹6.73 crores, driven by strong revenue momentum and margin expansion. However, the stock's extraordinary 425.22% rally over the past year has pushed valuations to concerning levels, with the company now trading at a P/E multiple of 70x—nearly four times the industry average—raising questions about sustainability despite the underlying operational strength."
      },
      {
        "title": "Titan Biotech Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/titan-biotech-ltd-is-rated-hold-by-marketsmojo-4024270",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/TitanBiotechLtd_mojoScore_4024270.png",
        "date": "2026-05-31 10:10:31",
        "description": "Titan Biotech Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 19 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 31 May 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Titan Biotech Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/titan-biotech-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4012646",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/TitanBiotechLtd_technicaldot_4012646.png",
        "date": "2026-05-26 08:04:42",
        "description": "Titan Biotech Ltd, a micro-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a strong year-to-date return of 124.2% and a 5.0% gain on the day, the company’s technical profile has moderated from a previous Buy rating to Hold, signalling a more cautious outlook among market participants."
      }
    ],
    "total": 443,
    "sid": "779371",
    "stock_news_url": "https://www.marketsmojo.com/news/titan-biotech-779371"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "01-Jun-2026",
      "details": "Newspaper publication of the Audited Financial Results (Standalone & Consolidated) for fourth quarter and year ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Of Titan Biotech Limited Held Today I.E. 30Th May 2026",
      "datetime": "30-May-2026",
      "details": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors at its meeting held today i.e. Saturday 30th May 2026 Approval of Audited Financial Results For The Fourth Quarter And Year Ended 31st March 2026 Recommendation of Dividend re appointment of Cost Auditor and Appointment of Scrutinizer",
      "source": "BSE"
    },
    {
      "caption": "Corporate Action-Board to consider Dividend",
      "datetime": "30-May-2026",
      "details": "The Board of Director of the Company has recommended a dividend of Rs. 0.50 paisa per Equity Share",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Titan Biotech Ltd has declared <strong>20%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Titan Biotech Ltd has announced <strong>2:10</strong> stock split, ex-date: 20 Feb 26",
          "dt": "2026-02-20",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Titan Biotech Gains 0.24%: 4 Key Factors Driving the Week’s Momentum

2026-06-13 17:09:58

Key Events This Week

1 June: Stock opens strong at Rs.456.60, up 3.48%

2 June: Titan Biotech upgraded to Buy by MarketsMOJO

4 June: Technical momentum shifts to mildly bullish amid mixed signals

5 June: Week closes steady at Rs.442.30, outperforming Sensex

Week Open

Rs.441.25

Week Close

Rs.442.30...

Read full news article

Titan Biotech Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals

2026-06-09 08:24:00

Titan Biotech Ltd, a micro-cap player in the Specialty Chemicals sector, has seen its investment rating downgraded from Buy to Hold as of 8 June 2026. This revision reflects a nuanced assessment across four key parameters: quality, valuation, financial trend, and technical indicators. Despite robust recent financial performance and impressive long-term returns, evolving technical signals and valuation concerns have tempered the overall outlook.

Read full news article

Titan Biotech Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-06-04 08:03:40

Titan Biotech Ltd, a micro-cap player in the specialty chemicals sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a recent downgrade in daily price performance, the company’s long-term returns remain robust, prompting a reassessment of its technical outlook and investment potential.

Read full news article

Are Titan Biotech Ltd latest results good or bad?

2026-06-02 19:26:39

Titan Biotech Ltd's latest financial results for Q4 FY26 reveal a mixed operational performance characterized by significant year-on-year growth alongside sequential declines. The consolidated net profit reached ₹6.73 crores, reflecting a notable year-on-year increase of 66.17%. However, this figure represents a decline of 21.10% compared to the previous quarter. Similarly, net sales for the quarter amounted to ₹48.83 crores, which is a substantial year-on-year growth of 38.84%, yet it shows a sequential decrease of 13.59% from Q3 FY26. The operating margin for the quarter stood at 19.89%, marking a significant improvement of 690 basis points from the same quarter last year, indicating effective cost management and operational leverage despite inflationary pressures. The average return on equity (ROE) of 21.23% demonstrates strong capital efficiency, positioning the company favorably within its industry. ...

Read full news article

Titan Biotech Ltd Upgraded to Buy on Strong Financials and Technical Momentum

2026-06-02 08:28:21

Titan Biotech Ltd, a micro-cap player in the specialty chemicals sector, has seen its investment rating upgraded from Hold to Buy as of 1 June 2026. This upgrade reflects a comprehensive improvement across key parameters including quality, valuation, financial trends, and technical indicators, signalling renewed investor confidence in the company’s prospects.

Read full news article

Titan Biotech Ltd Sees Bullish Momentum Shift Amid Technical Upgrades

2026-06-02 08:06:37

Titan Biotech Ltd, a micro-cap player in the Specialty Chemicals sector, has exhibited a notable shift in its technical momentum, signalling a bullish outlook after a period of mild bullishness. The stock’s recent price action, combined with evolving technical indicators such as MACD, RSI, and moving averages, suggests an improving trend that investors should closely monitor amid its strong long-term returns.

Read full news article

Titan Biotech Q4 FY26: Strong Growth Momentum Marred by Valuation Concerns

2026-06-01 23:47:58

Titan Biotech Ltd., the New Delhi-based speciality chemicals manufacturer, reported robust financial performance for Q4 FY26, with consolidated net profit surging 66.17% year-on-year to ₹6.73 crores, driven by strong revenue momentum and margin expansion. However, the stock's extraordinary 425.22% rally over the past year has pushed valuations to concerning levels, with the company now trading at a P/E multiple of 70x—nearly four times the industry average—raising questions about sustainability despite the underlying operational strength.

Read full news article

Titan Biotech Ltd is Rated Hold by MarketsMOJO

2026-05-31 10:10:31

Titan Biotech Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 19 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 31 May 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Titan Biotech Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-26 08:04:42

Titan Biotech Ltd, a micro-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a strong year-to-date return of 124.2% and a 5.0% gain on the day, the company’s technical profile has moderated from a previous Buy rating to Hold, signalling a more cautious outlook among market participants.

Read full news article

View All News